Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00098462 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn as study never opened

Conditions

Lung Cancer

Interventions

DRUG: gefitinib
DRUG: sirolimus

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]